Home > Boards > US OTC > Medical - Drugs > Telo Genomics Corp. (TDSGF)

3D Signatures bullish profile in Tailwinds Research for 2018

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
petunia1 Member Profile
 
Followed By 3
Posts 146
Boards Moderated 0
Alias Born 09/21/10
160x600 placeholder
petunia1   Sunday, 01/07/18 03:48:02 PM
Re: None
Post # of 58 
3D Signatures bullish profile in Tailwinds Research for 2018

By Daniel Carlson - January 5, 2018

3-D Signatures (DXD.V): for 3DS, 2017 was a year to forget. The stock went down dramatically on the back of a very poor financing effort. However, like the Phoenix, sometimes big disasters can turn into outstanding revivals. 3DS is poised to enter into several partnerships for its interesting technology. Meanwhile, the stock’s valuation discounts all success. I expect shares to advance in lockstep with the company’s development of their telomere technology and for 2018 to mark a dramatic turnaround for the Company.

http://bit.ly/2D4nUUc



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist